Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature
Authors
Keywords
Gemcitabine, Gefitinib, Erlotinib, Lapatinib, Epidermal Growth Factor Receptor Mutation
Journal
CLINICAL PHARMACOKINETICS
Volume 55, Issue 3, Pages 297-311
Publisher
Springer Nature
Online
2015-08-20
DOI
10.1007/s40262-015-0319-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
- (2015) J. L. Pokorny et al. CLINICAL CANCER RESEARCH
- Drug Transporters in the Central Nervous System
- (2015) Bruno Stieger et al. CLINICAL PHARMACOKINETICS
- Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: From discovery to patients
- (2015) ECM de Lange et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
- (2015) O. van Tellingen et al. DRUG RESISTANCE UPDATES
- Targeting cancer with kinase inhibitors
- (2015) Stefan Gross et al. JOURNAL OF CLINICAL INVESTIGATION
- Analyzing the blood–brain barrier: The benefits of medical imaging in research and clinical practice
- (2015) Yoash Chassidim et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Lapatinib concentration in cerebrospinal fluid in two patients with HER2-positive metastatic breast cancer and brain metastases
- (2014) S. Gori et al. ANNALS OF ONCOLOGY
- Irinotecan and temozolomide brain distribution: a focus on ABCB1
- (2014) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Transporter-Based Delivery of Anticancer Drugs to the Brain: Improving Brain Penetration by Minimizing Drug Efflux at the Blood-Brain Barrier
- (2014) Ngoc On et al. CURRENT PHARMACEUTICAL DESIGN
- Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
- (2014) Aki Morikawa et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- Erlotinib in combination with pemetrexed/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure
- (2014) Haihong Yang et al. Targeted Oncology
- Temozolomide down-regulates P-glycoprotein in human blood–brain barrier cells by disrupting Wnt3 signaling
- (2013) Chiara Riganti et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- (2013) A. Broniscer et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- Targeted Therapies in Brain Metastases
- (2013) Nancy U. Lin Current Treatment Options in Neurology
- Etravirine in CSF is highly protein bound
- (2013) A. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Blood–brain barrier structure and function and the challenges for CNS drug delivery
- (2013) N. Joan Abbott JOURNAL OF INHERITED METABOLIC DISEASE
- A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study
- (2013) Maryam Fouladi et al. JOURNAL OF NEURO-ONCOLOGY
- Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases
- (2013) Priya Kumthekar et al. JOURNAL OF NEURO-ONCOLOGY
- Utility of CSF in translational neuroscience
- (2013) Elizabeth C. M. de Lange JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications
- (2013) Richard J. Shannon et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: A report from the Children's Oncology Group
- (2013) T. J. MacDonald et al. NEURO-ONCOLOGY
- Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia
- (2012) Katalin Csordas et al. ANTI-CANCER DRUGS
- Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
- (2012) J. L. Rubenstein et al. BLOOD
- Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
- (2012) Yosuke Togashi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting the PI3K Pathway in the Brain--Efficacy of a PI3K Inhibitor Optimized to Cross the Blood-Brain Barrier
- (2012) L. Salphati et al. CLINICAL CANCER RESEARCH
- Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma
- (2012) Jing Zhao et al. Clinical Lung Cancer
- Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
- (2012) Nitzan Gonen et al. DRUG RESISTANCE UPDATES
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The Design and Identification of Brain Penetrant Inhibitors of Phosphoinositide 3-Kinase α
- (2012) Timothy P. Heffron et al. JOURNAL OF MEDICINAL CHEMISTRY
- Examination of blood–brain barrier (BBB) integrity in a mouse brain tumor model
- (2012) Ngoc H. On et al. JOURNAL OF NEURO-ONCOLOGY
- Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid
- (2012) Hong-Sheng Zhou et al. LEUKEMIA & LYMPHOMA
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study
- (2012) Susan M. Blaney et al. PEDIATRIC BLOOD & CANCER
- Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
- (2012) Igor Vivanco et al. Cancer Discovery
- Modern methods for delivery of drugs across the blood–brain barrier
- (2011) Yan Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy
- (2011) Takeshi Masuda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
- (2011) Yosuke Togashi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
- (2011) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors
- (2011) Matthias Scheffler et al. CLINICAL PHARMACOKINETICS
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
- (2011) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of Brain Metastases
- (2011) Lakshmi Nayak et al. Current Oncology Reports
- Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
- (2010) Filipa Lourenço Cardoso et al. BRAIN RESEARCH REVIEWS
- Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies
- (2010) Philipp Kiewe et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
- (2010) Robert J. Morgan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation
- (2010) M. A. Elmeliegy et al. CLINICAL CANCER RESEARCH
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
- (2010) R. Nau et al. CLINICAL MICROBIOLOGY REVIEWS
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
- (2010) Jennifer L. Clarke et al. JOURNAL OF NEURO-ONCOLOGY
- Cerebrospinal Fluid Concentration of Erlotinib and its Active Metabolite OSI-420 in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer
- (2010) Yosuke Togashi et al. Journal of Thoracic Oncology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies
- (2009) H. A. Burris et al. CLINICAL CANCER RESEARCH
- The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation
- (2009) J. Portnow et al. CLINICAL CANCER RESEARCH
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- Targeting protein kinases in central nervous system disorders
- (2009) Laura K. Chico et al. NATURE REVIEWS DRUG DISCOVERY
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
- (2008) J. Sigmond et al. ANNALS OF ONCOLOGY
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
- (2008) K. Porkka et al. BLOOD
- Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
- (2008) Rupert Bartsch et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients
- (2008) L. Rosso et al. CANCER RESEARCH
- High-Dose Methotrexate in Osteosarcoma: Let the Questions Surcease—Time for Final Acceptance
- (2008) Norman Jaffe et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study
- (2008) Jaishri O. Blakeley et al. JOURNAL OF NEURO-ONCOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
- (2008) HF Petereit et al. Multiple Sclerosis Journal
- Successful Treatment of Carcinomatous Meningitis with Gefitinib in a Patient with Lung Adenocarcinoma Harboring a Mutated EGF Receptor Gene
- (2008) Tatsuro Fukuhara et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now